Clinical and symptom scores are significantly correlated with fecal microbiota features in patients with symptomatic uncomplicated diverticular disease: a pilot study

被引:45
|
作者
Kvasnovsky, Charlotte L. [1 ,2 ,3 ]
Leong, Lex E. X. [4 ]
Choo, Jocelyn M. [4 ]
Abell, Guy C. J. [4 ]
Papagrigoriadis, Savvas [2 ]
Bruce, Kenneth D. [3 ]
Rogers, Geraint B. [4 ]
机构
[1] Univ Maryland, Med Ctr, Dept Surg, Baltimore, MD 21201 USA
[2] Kings Coll Hosp London, Dept Colorectal Surg, London, England
[3] Kings Coll London, Div Transplantat Immunol & Mucosal Biol, London, England
[4] South Australian Hlth & Med Res Inst, Div Microbiome Res, Adelaide, SA, Australia
关键词
diverticular disease; fecal microbiota; Akkermansia; IRRITABLE-BOWEL-SYNDROME; INTESTINAL GAS TRANSIT; GUT MICROBIOTA; ULCERATIVE-COLITIS; METABOLOME; MANAGEMENT; REMISSION; DYSBIOSIS; RESPONSES; COLON;
D O I
10.1097/MEG.0000000000000995
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
BackgroundThere is growing consensus that symptomatic uncomplicated diverticular disease is a chronic inflammatory condition, and that alterations in the fecal microbiota may contribute to its pathogenesis.ObjectiveThe aim of this study was to relate the fecal microbiota composition in symptomatic uncomplicated diverticular disease to measures of inflammation, symptoms, and history of previous acute diverticulitis.Participants and methodsFecal microbiota composition in 28 individuals with symptomatic uncomplicated diverticular disease was characterized by 16S RNA gene amplicon sequencing. Microbiota composition was related to clinical history, symptom and inflammation measures, and demographic variables.ResultsPrevious acute diverticulitis was associated with higher relative abundance of Pseudobutyrivibrio, Bifidobacterium, Christensenellaceae family, and Mollicutes RF9 order (P=0.004, 0.006, 0.010, and 0.019, respectively), but not microbiota alpha or beta diversity. A higher bloating severity score was significantly correlated with a higher relative abundance of Ruminococcus (P=0.032), and significantly inversely correlated with the relative abundance of the Roseburia (P=0.002). Fecal calprotectin levels were positively correlated with alpha diversity (Shannon index, P=0.005) and the relative abundance of Lactobacillus (P=0.004). Pain score was positively correlated with the relative abundance of Cyanobacterium (adjusted P=0.032).ConclusionPatient symptoms in symptomatic diverticular disease are significantly correlated with features of the fecal microbiota. Our findings suggest the potential utility of therapies that target intestinal microbiology, such as dietary prebiotic supplements.
引用
收藏
页码:107 / 112
页数:6
相关论文
共 14 条
  • [1] IMPACT OF TREATMENTS ON FECAL MICROBIOTA AND FECAL METABOLOME IN SYMPTOMATIC UNCOMPLICATED DIVERTICULAR DISEASE OF THE COLON: A PILOT STUDY
    Laghi, L.
    Mastromarino, P.
    Elisei, W.
    Capobianco, D.
    Zhu, C-L
    Picchio, M.
    Giorgetti, G.
    Brandimarte, G.
    Tursi, A.
    JOURNAL OF BIOLOGICAL REGULATORS AND HOMEOSTATIC AGENTS, 2018, 32 (06) : 1421 - 1432
  • [2] Assessment of Fecal Microbiota and Fecal Metabolome in Symptomatic Uncomplicated Diverticular Disease of the Colon
    Tursi, Antonio
    Mastromarino, Paola
    Capobianco, Daniela
    Elisei, Walter
    Miccheli, Alfredo
    Capuani, Giorgio
    Tomassini, Alberta
    Campagna, Giuseppe
    Picchio, Marcello
    Giorgetti, GianMarco
    Fabiocchi, Federica
    Brandimarte, Giovanni
    JOURNAL OF CLINICAL GASTROENTEROLOGY, 2016, 50 : S9 - S12
  • [3] Can gut microbiota explain acute diverticulitis occurrence in patients with symptomatic uncomplicated diverticular disease?
    Tursi, Antonio
    Procaccianti, Giorgia
    D'amico, Federica
    DE Bastiani, Rudi
    Turroni, Silvia
    BIOSCIENCE OF MICROBIOTA FOOD AND HEALTH, 2025, 44 (01) : 1 - 3
  • [4] Clinical features of symptomatic uncomplicated diverticular disease: a multicenter Italian survey
    Bruno Annibale
    Edith Lahner
    Giovanni Maconi
    Paolo Usai
    Santino Marchi
    Gabrio Bassotti
    Giovanni Barbara
    Rosario Cuomo
    International Journal of Colorectal Disease, 2012, 27 : 1151 - 1159
  • [5] Clinical features of symptomatic uncomplicated diverticular disease: a multicenter Italian survey
    Annibale, Bruno
    Lahner, Edith
    Maconi, Giovanni
    Usai, Paolo
    Marchi, Santino
    Bassotti, Gabrio
    Barbara, Giovanni
    Cuomo, Rosario
    INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, 2012, 27 (09) : 1151 - 1159
  • [6] Efficacy and safety of a new nutraceutical formulation in managing patients with symptomatic uncomplicated diverticular disease: a 12-month, prospective, pilot study
    Tursi, Antonio
    Brandimarte, Giovanni
    Di Mario, Francesco
    Elisei, Walter
    Picchio, Marcello
    JOURNAL OF GASTROINTESTINAL AND LIVER DISEASES, 2018, 27 (02) : 201 - 203
  • [7] Moderate to Severe and Prolonged Left Lower-abdominal Pain is the Best Symptom Characterizing Symptomatic Uncomplicated Diverticular Disease of the Colon A Comparison With Fecal Calprotectin in Clinical Setting
    Tursi, Antonio
    Elisei, Walter
    Picchio, Marcello
    Giorgetti, Gian M.
    Brandimarte, Giovanni
    JOURNAL OF CLINICAL GASTROENTEROLOGY, 2015, 49 (03) : 218 - 221
  • [8] Prospective, five-year follow-up study of patients with symptomatic uncomplicated diverticular disease
    Salem, Tarek A.
    Molloy, Richard G.
    O'Dwyer, Patrick J.
    DISEASES OF THE COLON & RECTUM, 2007, 50 (09) : 1460 - 1464
  • [9] Efficacy of a New Nutraceutical Formulation in Patients with Symptomatic Uncomplicated Diverticular Disease (SUDD): a Prospective Observational Study
    D'Amico, Ferdinando
    Fiorini, Giulia
    Tursi, Antonio
    Saracino, Ilaria Maria
    Pavoni, Matteo
    Danese, Silvio
    Vaira, Dino
    JOURNAL OF GASTROINTESTINAL AND LIVER DISEASES, 2019, 28 : 49 - 52
  • [10] Micro-encapsulated and colonic-release sodium butyrate modulates gut microbiota and improves abdominal pain in patients with symptomatic uncomplicated diverticular disease
    Tursi, Antonio
    Procaccianti, Giorgia
    De Bastiani, Rudi
    Turroni, Silvia
    D'Amico, Federica
    Allegretta, Leonardo
    Antonino, Natale
    Baldi, Elisabetta
    Casamassima, Carlo
    Casella, Giovanni
    Ciuffi, Mario
    De Bastiani, Marco
    Lazzarotto, Lorenzo
    Licci, Claudio
    Mancuso, Maurizio
    Penna, Antonio
    Pranzo, Giuseppe
    Sanna, Guido
    Tosetti, Cesare
    Zamparella, Maria
    Picchio, Marcello
    FRONTIERS IN MEDICINE, 2025, 12